|
|
||||||||
1From the Singapore National Eye Center, Singapore; the 2Singapore Eye Research Institute, Singapore; the 3Department of Ophthalmology, National University of Singapore, Singapore; 4Louisiana State University Eye Center, LSU Health Sciences Center, New Orleans, Louisiana; and the 5Department of Dermatology, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
PURPOSE. To investigate the use of a multistep serum-free culture system in developing a conjunctival epithelial equivalent with improved in vitro and in vivo proliferative properties and to evaluate the effect of serum supplementation and culture conditions on the proliferative capacity of these cells.
METHODS. Conjunctival epithelial cells were cultivated on human amniotic membrane (HAM) in a multistep serum-free culture system, under submerged and air-lifted conditions. The bromodeoxyuridine (BrdU) ELISA proliferation assay, colony-forming efficiency (CFE), and number of cell generations were compared with those in serum-containing medium. The in vivo proliferative capability of the tissue-constructs were evaluated by xenotransplantation to SCID mice. Cultured cells were evaluated for the expression of keratin-4, -19, and -3, as well as MUC5AC goblet cell mucin.
RESULTS. The epithelial cells cultivated in serum-free medium (BrdU absorbance, 1.91 ± 0.08; cell generations, 25.6 ± 4.5) were more proliferative than those cultivated in serum-containing medium (BrdU absorbance, 1.06 ± 0.08; cell generations, 12.1 ± 3.0). The serum-freederived epithelial equivalents demonstrated a significant increase in proliferation and stratification after transplantation. Cells that were air lifted for 6 and 12 days had a reduced proliferative capacity in vitro and in vivo compared with submerged cultures. Cultured cells expressed keratin-4 and -19, and MUC5AC mRNA was detected by RT-PCR. Electron microscopy demonstrated a basal lamina with numerous hemidesmosomes.
CONCLUSIONS. This is a multistep serum-free culture system for developing a conjunctival epithelial equivalent with improved proliferative and structural properties, which are crucial for enhancing graft survival and regeneration of the conjunctival surface after clinical transplantation.
This article has been cited by other articles:
![]() |
S. Yokoo, S. Yamagami, T. Usui, S. Amano, and M. Araie Human Corneal Epithelial Equivalents for Ocular Surface Reconstruction in a Complete Serum-Free Culture System without Unknown Factors Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2438 - 2443. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, J. Li, D. T. H. Tan, and R. W. Beuerman The Eyelid Margin: A Transitional Zone for 2 Epithelial Phenotypes Arch Ophthalmol, April 1, 2007; 125(4): 523 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Di Girolamo, J. Chui, D. Wakefield, and M. T Coroneo Cultured human ocular surface epithelium on therapeutic contact lenses Br. J. Ophthalmol., April 1, 2007; 91(4): 459 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, K.-i. Endo, and S. Kinoshita Identification of Human Oral Keratinocyte Stem/Progenitor Cells by Neurotrophin Receptor p75 and the Role of Neurotrophin/p75 Signaling Stem Cells, March 1, 2007; 25(3): 628 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tanioka, S. Kawasaki, K. Yamasaki, L. P. K. Ang, N. Koizumi, T. Nakamura, N. Yokoi, A. Komuro, T. Inatomi, and S. Kinoshita Establishment of a cultivated human conjunctival epithelium as an alternative tissue source for autologous corneal epithelial transplantation. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3820 - 3827. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawasaki, H. Tanioka, K. Yamasaki, N. Yokoi, A. Komuro, and S. Kinoshita Clusters of corneal epithelial cells reside ectopically in human conjunctival epithelium. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1359 - 1367. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Park, C. H. Lim, B.-M. Min, J. L. Lee, H.-Y. Chung, C.-K. Joo, C.-W. Park, and Y. Son The side population cells in the rabbit limbus sensitively increased in response to the central cornea wounding. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 892 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, L. P. K. Ang, H. Rigby, E. Sekiyama, T. Inatomi, C. Sotozono, N. J. Fullwood, and S. Kinoshita The use of autologous serum in the development of corneal and oral epithelial equivalents in patients with stevens-johnson syndrome. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 909 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. K. Ang, Z. Y. Cheng, R. W. Beuerman, S. H. Teoh, X. Zhu, and D. T. H. Tan The Development of a Serum-Free Derived Bioengineered Conjunctival Epithelial Equivalent Using an Ultrathin Poly({varepsilon}-Caprolactone) Membrane Substrate Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 105 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
L P K Ang, D T H Tan, C J Y Seah, and R W Beuerman The use of human serum in supporting the in vitro and in vivo proliferation of human conjunctival epithelial cells Br. J. Ophthalmol., June 1, 2005; 89(6): 748 - 752. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |